Related News
Sanofi picks Shanghai for R&D center
Print Edition
FRENCH pharmaceutical giant Sanofi opened a research hub in Shanghai yesterday, the company said, as foreign drug firms face government scrutiny after GlaxoSmithKline was found guilty of bribery last week.
The facility, the fifth global hub for the company and its first in Asia, groups 12 countries including China, Sanofi said.
The operation will employ 1,400 people, it said. Sanofi officials declined to give an investment figure.
“With the launch of the hub, we will continue to pioneer R&D (research and development) in Asia-Pacific,” said Frank Jiang, Sanofi’s head of R&D in Asia-Pacific.
Shanghai has sought to attract multinational companies to set up regional headquarters in the city with the number reaching 470 as of mid-year, according to state media.
The Shanghai facility will research and develop products in four broad areas — biopharmaceuticals, vaccinations, disease and animal health — in cooperation with other global hubs, company officials said.
Sanofi already has existing R&D capabilities in China, along with seven plants producing mainly for the China market, they said.
The opening comes just days after China fined UK drugmaker GSK 3 billion yuan (US$489 million) for bribery and gave jail terms of up to four years to five executives.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
